AYTU - Aytu BioScience, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Aytu BioScience, Inc.
Aytu BioScience Inc is engaged in acquiring, developing and commercializing products in the field of urology. It focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility.
IPO Date: May 23, 2017
Sector: Healthcare
Industry: Pharma
Market Cap: $22.28M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.09 | 4.89%
Avg Daily Range (30 D): $0.05 | 2.52%
Avg Daily Range (90 D): $0.05 | 2.19%
Institutional Daily Volume
Avg Daily Volume: 1.49M
Avg Daily Volume (30 D): .04M
Avg Daily Volume (90 D): .03M
Trade Size
Avg Trade Size (Sh.): 478
Avg Trade Size (Sh.) (30 D): 167
Avg Trade Size (Sh.) (90 D): 164
Institutional Trades
Total Institutional Trades: 60
Avg Institutional Trade: $1.63M
Avg Institutional Trade (30 D): $.76M
Avg Institutional Trade (90 D): $.76M
Avg Institutional Trade Volume: .01M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.59M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: 20.99K
 
News
Oct 7, 2026 @ 3:08 PM
Elite Pharmaceuticals vs. Aytu: Which CNS Stock Is...
Source: Na
Sep 22, 2026 @ 9:15 PM
Aytu BioPharma, Inc. (AYTU) Reports Q4 Loss, Beats...
Source: Zacks.Com
Sep 14, 2026 @ 9:35 PM
HeartSciences Inc. (HSCS) Reports Q1 Loss, Misses ...
Source: Na
Jul 17, 2024 @ 11:03 AM
Presenting on the Emerging Growth Conference 73 Da...
Source: N/A
Nov 15, 2023 @ 7:04 PM
Why Shapeways Holdings Shares Are Trading Lower By...
Source: Lisa Levin
Financials
  TTM Q4 2026 FY 2026
Basic EPS $-1.16 $.26 $-1.16
Diluted EPS
Revenue $57.57M $16.11M $57.57M
Gross Profit $36.82M $10.41M $36.82M
Net Income / Loss $-14.25M $-.02M $-14.25M
Operating Income / Loss $-8.32M $-.78M $-8.32M
Cost of Revenue $20.75M $5.7M $20.75M
Net Cash Flow $-4.64M $-.41M $-4.64M
PE Ratio    
Splits
Jan 06, 2023 1:20
Dec 09, 2020 1:10
Aug 13, 2018 1:20
Aug 29, 2017 1:20
Jul 01, 2016 1:12
Jun 10, 2015 11:134